| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |